日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma

MYC 依赖的从头丝氨酸和甘氨酸合成途径上调是 3 组髓母细胞瘤中可靶向的代谢弱点

Magretta Adiamah, Bethany Poole, Janet C Lindsey, Sarah Kohe, Alaide Morcavallo, Florence Burté, Rebecca M Hill, Helen Blair, Dean Thompson, Mankaran Singh, Shanel Swartz, Stephen Crosier, Tong Zhang, Oliver D K Maddocks, Andrew Peet, Louis Chesler, Ian Hickson, Ross J Maxwell, Steven C Clifford

Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

更正:靶向 WEE1 激酶作为高危和复发性急性淋巴细胞白血病中一种不依赖于 p53 的治疗策略

Bell, Hayden L; Blair, Helen J; Singh, Mankaran; Moorman, Anthony V; Heidenreich, Olaf; van Delft, Frederik W; Lunec, John; Irving, Julie A E

In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastoma

体内模型重现了儿童髓母细胞瘤的放射治疗过程和远期效应特征

Castle, Jemma; Shaw, Gary; Weller, Dominic; Fielder, Edward; Egnuni, Teklu; Singh, Mankaran; Skinner, Roderick; von Zglinicki, Thomas; Clifford, Steven C; Short, Susan C; Miwa, Satomi; Hicks, Debbie

Identification, management and pecuniary impact of major carbon footprint contributor in potato production system of north-west India

印度西北部马铃薯生产系统中主要碳足迹贡献者的识别、管理及其经济影响

Kumar, Prince; Sharma, Jagdev; Sharma, Anil; Singh, Mankaran; Nare, Brajesh; Kumar, Manoj

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

以 WEE1 激酶为靶点,作为高危复发性急性淋巴细胞白血病的 p53 独立治疗策略

Hayden L Bell, Helen J Blair, Mankaran Singh, Anthony V Moorman, Olaf Heidenreich, Frederik W van Delft, John Lunec, Julie A E Irving

Diagnosis of rabies using reverse-transcription polymerase chain reaction on post-mortem skin tissue specimens of the nasolabial plate in a rabies suspected cow: a case study

利用逆转录聚合酶链式反应对疑似狂犬病母牛鼻唇沟尸检皮肤组织标本进行狂犬病诊断:病例研究

Sharma, Anil Kumar; Prashar, Parinita; Bharti, Omesh Kumar; Thachamvally, Riyesh; Thakur, Rashmi; Kumar, Naveen; Shanmugasundaram, Karuppusamy; Singha, Harisankar; Bhattacharya, Tarun Kumar; Gulati, Baldev Raj; Isloor, Shrikrishna; Panda, Ashok Kumar; Sharma, Jyotsna; Hara, Mankaran; Knobel, Darryn

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia

hiPSC衍生的骨髓微环境揭示了白血病中微环境介导的治疗耐药性的临床可操作驱动因素

Deepali Pal ,Helen Blair ,Jessica Parker ,Sean Hockney ,Melanie Beckett ,Mankaran Singh ,Ricky Tirtakusuma ,Ryan Nelson ,Hesta McNeill ,Sharon H Angel ,Aaron Wilson ,Salem Nizami ,Sirintra Nakjang ,Peixun Zhou ,Claire Schwab ,Paul Sinclair ,Lisa J Russell ,Jonathan Coxhead ,Christina Halsey ,James M Allan ,Christine J Harrison ,Anthony V Moorman ,Olaf Heidenreich ,Josef Vormoor

Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics

沙丁胺醇硫酸盐、西替利嗪盐酸盐复方速崩片制剂的开发与评价:儿科和老年医学新型药物递送的新时代

Sharma, Deepak; Singh, Gurmeet; Kumar, Dinesh; Singh, Mankaran

Formulation Development and Evaluation of Fast Disintegrating Tablet of Cetirizine Hydrochloride: A Novel Drug Delivery for Pediatrics and Geriatrics

盐酸西替利嗪速崩片制剂的开发与评价:一种用于儿科和老年科的新型给药方式

Sharma, Deepak; Singh, Mankaran; Kumar, Dinesh; Singh, Gurmeet